insider24.ch
Back to the feed

Shareholding disclosure

Santhera Pharmaceuticals Holding AG

inSanthera Pharmaceuticals Holding AG

Collectively declared rate

4.14%

Threshold

Crossed upwards

Timeline

Published

24.01.2008

Transaction

01.12.2007

Transfer date

01.12.2007

Voting rights breakdown

Voting rights acquired4.14%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 3

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

T5370D5130

Beneficial owner

Heidelberg Innovation GmbH

Declared address

Heidelberg Innovation GmbH, Heidelberg

Santhera Pharmaceuticals (SWX: SANN) was informed by Heidelberg Innovation Fonds Management GmbH, Im Neuheimer Feld 581, DE-69120 Heidelberg, Germany, that the following funds under its management - Heidelberg Innovation GmbH & Co. BioScience Venture KG - Heidelberg Innovation BioScience Venture II GmbH & Co. KG - Heidelberg Innovation Parallel-Beteiligungs GmbH & Co. KGaA together hold 128,234 shares of Santhera Pharmaceuticals Holding AG, representing 4.14% of the voting rights of the shares registered in the Commercial Register. Beneficial owner of Heidelberg Innovation Fonds Management GmbH is Prof. Dr. Ulrich Abshagen, D-69469 Weinheim, Germany. Contact person at Heidelberg Innovation is Dr. Christoph Kronabel.

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open